Loading clinical trials...
Loading clinical trials...
A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx Influenza A/B + RSV Test at Point of Care Testing Sites
Conditions
Interventions
Swab
Locations
20
United States
MedHelp Urgent Care
Birmingham, Alabama, United States
Access Medical Center
Encinitas, California, United States
Madera Family Medical Group
Madera, California, United States
ImmunoE Health and Research
Centennial, Colorado, United States
Complete Family Care Research
Northglenn, Colorado, United States
ImmunoE Health and Research Center
Thornton, Colorado, United States
Start Date
February 6, 2020
Primary Completion Date
September 30, 2023
Completion Date
September 30, 2023
Last Updated
March 13, 2023
NCT07220109
NCT07092865
NCT07239583
NCT06355232
NCT04494412
NCT07204964
Lead Sponsor
LumiraDx UK Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions